Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Revenue (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Revenue for 3 consecutive years, with $183000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 169.12% year-over-year to $183000.0, compared with a TTM value of $849000.0 through Sep 2025, up 758.14%, and an annual FY2024 reading of $135000.0, changed N/A over the prior year.
  • Revenue was $183000.0 for Q3 2025 at SeaStar Medical Holding, down from $338000.0 in the prior quarter.
  • Across five years, Revenue topped out at $338000.0 in Q2 2025 and bottomed at -$433000.0 in Q1 2023.
  • Average Revenue over 3 years is $7750.0, with a median of $51500.0 recorded in 2024.
  • The sharpest move saw Revenue soared 117.77% in 2024, then skyrocketed 169.12% in 2025.
  • Year by year, Revenue stood at -$197000.0 in 2023, then skyrocketed by 117.77% to $35000.0 in 2024, then skyrocketed by 422.86% to $183000.0 in 2025.
  • Business Quant data shows Revenue for ICU at $183000.0 in Q3 2025, $338000.0 in Q2 2025, and $293000.0 in Q1 2025.